Quanterix (QTRX) Income from Non-Controlling Interests (2024 - 2025)
Quanterix (QTRX) posted Income from Non-Controlling Interests of -$68000.0 for Q2 2025, down 750.0% on a QoQ basis from -$8000.0 in Q1 2025, and up 61.14% year-over-year from -$42198.6 in Q2 2024.
Quanterix (QTRX) Income from Non-Controlling Interests (2024 - 2025) Analysis & Trends
Quanterix's Income from Non-Controlling Interests history runs 2 years deep, the most recent figure standing at -$68000.0 for Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.06 Bn | 175.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.66 Bn | 125.78 Bn | 3.81 Bn | - |
| 3 | Medtronic | 108.82 Bn | 99.60 Bn | 6.41 Bn | 16.00 Mn |
| 4 | Boston Scientific | 68.43 Bn | 66.98 Bn | 3.61 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 48.29 Bn | 44.61 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 28.37 Bn | 26.08 Bn | 1.98 Bn | 22.00 Mn |
| 7 | Dexcom | 28.29 Bn | 27.18 Bn | 750.30 Mn | - |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | - |
| 9 | Koninklijke Philips | 25.43 Bn | 22.31 Bn | 2.07 Bn | -5.85 Mn |
| 10 | Quanterix | 174.29 Mn | 75.03 Mn | 15.57 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -68,000.00 |
| Mar 31, 2025 | -8,000.00 |
| Jun 30, 2024 | -175,000.00 |
| Mar 31, 2024 | -607,000.00 |